Summa Health /ID# 269349

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Ovarian cancer

Running trials

• Active, not recruiting

  A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression

  NCT06365853· Phase 2· AbbVie· Source